Skip to main content
Top
Published in: Endocrine 2/2022

01-05-2022 | Letter to the Editor

ROC curves: stats, common sense, and caution

Authors: Fernando Chimela Chume, Joíza Lins Camargo

Published in: Endocrine | Issue 2/2022

Login to get access

Excerpt

We would like to thank Toft et al. [1] for their interest in our paper and taking the time to express their concerns. We also thank the Editors for providing us the opportunity to reply and discuss the issues raised in Toft et al.’s letter. …
Literature
3.
go back to reference American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 45(1 Suppl), S17–S38 (2022)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 45(1 Suppl), S17–S38 (2022)CrossRef
4.
go back to reference M. Li, J.R. Lan, J.L. Liang, X.L. Xiong, Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis. Eur. Rev. Med Pharm. Sci. 24(21), 11172–11186 (2020) M. Li, J.R. Lan, J.L. Liang, X.L. Xiong, Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis. Eur. Rev. Med Pharm. Sci. 24(21), 11172–11186 (2020)
Metadata
Title
ROC curves: stats, common sense, and caution
Authors
Fernando Chimela Chume
Joíza Lins Camargo
Publication date
01-05-2022
Publisher
Springer US
Published in
Endocrine / Issue 2/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03046-3

Other articles of this Issue 2/2022

Endocrine 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.